BIB · ProShares Ultra Nasdaq Biotechnology ETF
ProShares Trust
$120.00
-1.57%
At close · Sep 4
Net assets $73,651,927
Holdings231
1 month
+12.74%
Year to date
+50.43%
52-week range
$55.34–$126.40
30-session avg volume
11,093
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000018718
- Report date
- May 31, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Gilead Sciences, Inc. | GILD | $3,433,611 | 4.66% |
| Vertex Pharmaceuticals, Inc. | VRTX | $3,426,814 | 4.65% |
| Amgen, Inc. | AMGN | $3,301,552 | 4.48% |
| Regeneron Pharmaceuticals, Inc. | REGN | $2,360,755 | 3.21% |
| Alnylam Pharmaceuticals, Inc. | ALNY | $1,480,910 | 2.01% |
| Revolution Medicines, Inc. | RVMD | $1,153,698 | 1.57% |
| Biogen, Inc. | BIIB | $1,063,300 | 1.44% |
| Illumina, Inc. | ILMN | $921,213 | 1.25% |
| United Therapeutics Corp. | UTHR | $902,048 | 1.22% |
| Argenx SE | ARGX | $877,790 | 1.19% |
| Insmed, Inc. | INSM | $851,859 | 1.16% |
| Incyte Corp. | INCY | $711,910 | 0.97% |
| Viatris, Inc. | VTRS | $692,107 | 0.94% |
| Moderna, Inc. | MRNA | $688,974 | 0.94% |
| Guardant Health, Inc. | GH | $628,997 | 0.85% |
| Neurocrine Biosciences, Inc. | NBIX | $587,610 | 0.80% |
| Summit Therapeutics, Inc. | SMMT | $502,767 | 0.68% |
| Exelixis, Inc. | EXEL | $484,608 | 0.66% |
| Bridgebio Pharma, Inc. | BBIO | $474,885 | 0.64% |
| Medpace Holdings, Inc. | MEDP | $469,913 | 0.64% |
| Ionis Pharmaceuticals, Inc. | IONS | $467,339 | 0.63% |
| Axsome Therapeutics, Inc. | AXSM | $443,167 | 0.60% |
| Madrigal Pharmaceuticals, Inc. | MDGL | $421,188 | 0.57% |
| BioMarin Pharmaceutical, Inc. | BMRN | $407,332 | 0.55% |
| BioNTech SE | BNTX | $404,237 | 0.55% |
| Arrowhead Pharmaceuticals, Inc. | ARWR | $403,418 | 0.55% |
| Sanofi SA | SNY | $395,082 | 0.54% |
| Praxis Precision Medicines, Inc. | PRAX | $360,119 | 0.49% |
| Cytokinetics, Inc. | CYTK | $349,488 | 0.47% |
| BeOne Medicines Ltd. | ONC | $340,034 | 0.46% |
| Krystal Biotech, Inc. | KRYS | $333,752 | 0.45% |
| Tempus AI, Inc. | TEM | $324,219 | 0.44% |
| Abivax SA | ABVX | $301,203 | 0.41% |
| Nuvalent, Inc. | 670703107 | $298,605 | 0.41% |
| Halozyme Therapeutics, Inc. | HALO | $290,381 | 0.39% |
| ImmunityBio, Inc. | IBRX | $285,820 | 0.39% |
| Vaxcyte, Inc. | PCVX | $273,499 | 0.37% |
| Immunovant, Inc. | IMVT | $250,516 | 0.34% |
| Kymera Therapeutics, Inc. | KYMR | $245,644 | 0.33% |
| Protagonist Therapeutics, Inc. | PTGX | $235,061 | 0.32% |
| Mirum Pharmaceuticals, Inc. | MIRM | $226,447 | 0.31% |
| PTC Therapeutics, Inc. | PTCT | $226,129 | 0.31% |
| Rhythm Pharmaceuticals, Inc. | RYTM | $223,096 | 0.30% |
| Spyre Therapeutics, Inc. | SYRE | $213,518 | 0.29% |
| Cogent Biosciences, Inc. | COGT | $209,830 | 0.28% |
| CG oncology, Inc. | CGON | $194,532 | 0.26% |
| Scholar Rock Holding Corp. | SRRK | $186,009 | 0.25% |
| Centessa Pharmaceuticals plc | CNTA | $175,858 | 0.24% |
| Caris Life Sciences, Inc. | CAI | $174,406 | 0.24% |
| Ligand Pharmaceuticals, Inc. | LGND | $170,723 | 0.23% |